4-Amino-2-methylquinoline

We are 4-Amino-2-methylquinoline CAS:6628-04-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  4-Amino-2-methylquinoline
CAS.NO:  6628-04-2
Synonyms:
4-Quinolinamine, 2-methyl-
4-Aminoquinaldine

Molecular Formula: C7H6ClNO2
Molecular Weight: 171.58100

Physical and Chemical Properties:
Density: 1.169g / cm3
Boiling point: 333 ° C (lit.)
Melting point: 162-166 ° C (lit.)
Flash point: 333 ° C
Refractive index:  1.682

Specification:
Appearance: Pale Yellow to White Powder
Purity:≥98.0%
Moisture:<1.0%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Store in a cool, dry place. Store in a tightly closed container.
Application:Intermediates of Dequalinium chloride CAS:522-51-0.

Related News: Fate Therapeutics has exclusively licensed from MSK foundational intellectual property covering the production and composition of iPSC-derived T cells.delta-valerolactona CAS:542-28-9 China has granted conditional approval to its first self-developed treatment for Alzheimer’s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug.2- [4- (aminometil) fenoxi] -N, N-dimetiletanamina CAS:20059-73-8 China has granted conditional approval to its first self-developed treatment for Alzheimer’s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug.N- (3-cloro-4-fluorofenil) -7-metoxi-6-nitroquinazolin-4-amina CAS:179552-74-0 This is very visible in herbal medicines in which the API is frequently a combination of several mixtures and/or substances which when used together cause pharmacological activity on the body.A key publication in a preclinical model demonstrated rigosertib’s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: “A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.” Cell 165, 643).